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T he effect of ora l isotretinoin (13-cis-retinoic acid) on in 
vivo chemotactic responses was studied longitudinally in 
7 patients with cystic acne. As m easured in a microchamber 
chemotaxis assay, both monocyte and neutrophil chemo-
taxis were inhibited 98% (p < 0.001) during isotretinoin 
treatment. In vivo chem otactic responses returned to nor-
mal within 2 months of cessation o f trea tment. Biopsies 
of skill chamber sites from patients on iso tretinoin showed 
no significant derm al or epiderm al leukocytic accumulation 
in response to autologous zymosan-activated serum, 
w hereas chambers from con trols showed extensive neu-
C ystic acne is a common disease of adolescents and youn g adu lts characteri zed by follicular hyperkera-tosis, increased sebum production, and dermal in-filtration of neutrophils in response to chemoattrac-tants produced by bacteria in occluded sebaceous 
follicles [1 ,2). Systemic retinoids have revolutionized acne therapy 
by providing a highl y effectiv e treatment for recalci trant cystic 
acne with predictable, largely reversible side effects (3). Topical 
tretinoin (Retin-A) and system ic isotretinoin reverse the follicular 
hyperkeratosis which is an important fac tor in the development 
of primary acne lesions [4,5) . In addition, iso tretinoin reversibly 
inhibits sebum production in patients with cysti c acne (6), and 
probably affects the bacterial population of sebaceous follicles 
even though isotretinoin itself is not antibacterial [5J . 
Plewig and Wagner raised the possibility that retinoids might 
have potent neutrophil inhibitory effects when they showed that 
isotretinoin inhibited pustule formation in potassium iodide patch 
tests (7). Ca misa and colleagues reported that isotretinoin ;'lhib-
ited neut rophil enzy me release and superoxide anion fo rm ati on, 
but not neutrophil chemotaxis, after in vitro incubation (8). Shal-
ita and Lee reported that isotretinoin inhibited neutrophil chem-
iluminescence in vitro, but that chemotaxis was inhibited only at 
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trophilic infdtrates even in the epidermis. In contrast, in 
vitro chemotactic responses of neutrophils and m onocytes 
from patients on iso tretinoin were not diminished. Sera 
and plasm a from patients on iso tretinoin contained no in-
hibitors of ch emotaxis, and activated sera from these pa-
tients were excellent attractants for norm al monocytes. We 
postulate that iso tretinoin produces significant anti-inflam-
matory effects by inhibition of monocyte and neutrophil 
chemotaxis across intact biologic barriers in vivo.) Invest 
DermatoI 89:38-43, 1987 
suprapharm acologic concentrations [9 ). We report evidence that 
pat ients takin g isotretinoin show 98% inhibition of both mono-
cyte and neutrophil chemotaxis in vivo using a technique that 
quantitates migra tion across mea ningful biologic barriers. We also 
report that thi s effect is not a direct effect on cell movement as 
measured by chemotaxis across standard filter barriers in vitro 
nor on generation of chemoa ttractants. We hypothesize that is-
o tretin oin is a potent anti-inflammatory agent by virtue of its 
profound inhibition of migra tion of monocytes and neutrophils 
across biologic barriers in vivo. 
MATE RIALS AND METHODS 
Patients Seven patients w ith severe cys ti c acne unresponsive to 
standard trea tment were followed longitudinally for 6 months. 
Before treatment with isotretinoin , all other acne medi ca tions 
were withdraw n for 1 month . Patients were treated with 1.5 
mg/kg isotretin oin (Accutane, Hoffmann-La Roche, Nutley, N ew 
Jersey) for 2 months, and then the dose was decreased to 0.5 
mg/kg for 2 additional months. Laboratory tests were performed 
before trea tment (0 months), durin g treatment (2 and 4 months), 
and 2 months after treatment (6 months). These tests included in 
vivo and in vit ro neutrophil chemotaxis, CBC with differential, 
serum cholesterol and triglycerides, liver function tests, and uri-
nalysis. Plasma and sera from patients were also frozen for tests 
of chemotactant generation and inhibition of chemotaxis. 
In Vivo Chemotaxis The response of monocytes and neutro-
phils to autologous zy mosan-activated serum (ZAS) in these sub-
j ects was evaluated by a previously described microchamber dif-
ferential chemotaxis technique [1 0,1 1) . In brief, S mm-diameter 
abrasions (4 per subj ect) were produ ced by tape-stripping of the 
epidermis of the volar surface of the forearm. Duplicate small 
plexiglass chambers of 0.2 ml volume were fill ed with .either 50% 
autologous ZAS diluted in H anks' balanced sa lt solution (HBSS) 
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or w ith HBSS alone. T he att ractant and sk in were separated by 
a sand wich o f 3- and 5-JLm pore Nucleopore filters (Nucleopore, 
Pleasanton, Ca li fo rni a). The chambers were left in place on the 
skin for 16 h, and then the filters and chamber fluid were removed 
for counting. 
The filter sa nd wich was separated and sta ined for alpha napthyl 
acetate es terase (A NA es terase) act ivity and counterstained for 
nuclear detail with methyl green . Ten random fields (400 x) were 
counted on each fi lter, and the number of monocy tes and neu-
trophils was multiplied by a conversion factor to give the total 
value over the 5 mm-diameter abrasion. The chamber fluid was 
counted in a hemocytometer and differential was performed by 
stainin g of a sa mple for ANA esterase. The to tal number of 
monocytes and neutrophils was determined by adding the counts 
from filter and chamber. 
C hemota xis was defined as the number of cells migra ted to 
ZAS minus the number migrated to HBSS. The total neutrophils 
and monocytes migrated at each stud y interval were averaged 
and the mea ns com pared using Stud ent 's I-test. . 
In Vitro Chemotaxis At each study interva l, peripheral blood 
cells from each subj ect were collected in heparinized syringes and 
separa ted into neutrop hil-enriched and monocyte-enri ched pop-
ulations by either dextran sed imentation or Ficoll-h ypaque dif-
ferential centrifugation , respectively, using previously described 
techniques (1 2]. Control neutrophils and monocytes from normal 
human volunteers were studi ed concurrently . Zymosan-activated 
norma l human serum diluted 50% in HBSS was used as a positi ve 
attractant and HBSS containing human serum albumin (1 mg/ml , 
Calbiochem) was used as a negative control. C hemotaxis was 
measured as migration through chemotactic fi lters placed in N eu-
roprobe blind-well chambers: N eutrophil migration was through 
3-JLm Nucleopore filters after 2-h incubation and monocyte mi-
gration was through 5-JLm Nucleopo re filters after 90-min in-
cubation. The to tal number of migrated monocytes and neut ro-
phils was visually counted in 20 random fi elds at 1000 x in filters 
from chambers conta ining either ZAS or negative control. C he-
motaxis was defined as the difference between the number of cell s 
that migra ted to ZAS ITlinus the number that migrated to HESS. 
Patient chemotaxis at each time point was compared with the 
normal con trols and expressed as percent of norm al control. T he 
means of all 7 subjects at each time point were compared using 
Student 's I-test. 
Effect of Patients' Sera and Plasma on Chemotaxis Sera 
and plasma from the 7 subj ects at 0, 2, 4, and 6 months of study 
were frozen and tested for their effects on chemotaxis. Sera from 
normal controls and from 3 patients w ith acne at 0 months (pre-
treatment) and 4 months (maximal isotretinoin effect on in vivo 
chemotaxis) were activa ted with zymosan and used as attractants 
in standard chemotactic assays. The cellular migration of mono-
cytes to attractants from normal contro ls and patients with acne 
before and during isotretinoin treatment were compared to see 
whether the drug induced an abnorm ality in complement acti-
vation. 
In addition, the plasma or sera from 3 patients taking isotre-
tinoin an d from 3 normal controls were added in equa l va lues to 
monocytes and neutrophils in RPMI , and incubated for 30 min 
in a darkened refrigerato r. The cell s were then tested in standard 
chemotaxis assays to see whether isotretinoin or its metabolites 
in patien ts' sera or plasma wo uld directly inhibit the migration 
of monocytes and neutrophil s obtained fro m controls. Sera and 
plasma from 2, 4, and 6 months on study were compared . 
Possible Ambient Light Effects on In Vitro Chemotaxis 
Retinoids in so lu tion are sensitive to the effects of ambien t light 
(13], and we were concerned that casual exposure to light between 
centrifugations might inactiva te retinoid metabolites and invali-
date our in vitro chemotactic results using cells from retinoid-
treated patients or plas ma and sera from retinoid-treated subj ects. 
Therefore, we performed a series of monocyte and neutroph il 
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chemotaxis experiments to test the effects of ambient laboratory 
light on cells from patients treated for at least 2 months w ith 1. 5 
mg/ kg of isotretinoin . Cells [rom each subj ect were separated 
in to two aliquots: one aliquot was separated, was hed, added to 
chemotaxis chambers, and harvested und er yellow li ght (rec-
ommended for handling retinoids), and one aliquot was handled 
in the same way under normal laboratory li ght. 
RESULTS 
All 7 patients had impressive clinical responses to oral isotretinoin 
therapy. T hey developed the expected profile of signs and symp-
toms of isotretinoin treatment. Total white blood cell count, as 
well as neut rophil , monocyte, and lymphocyte counts were not 
significa ntl y altered on the dose of iso tretinoin used. Liver func-
tion tests, tests of renal function, and cholesterol and triglyceride 
levels were not unusuall y elevated. 
The effect of isotretinoin on monocyte and neutrophil che-
motaxis in vivo in 7 patients with acne taking isotretinoin is 
shown in Fig 1, in w hich the number of monocytes and neutro-
phils migrating into microchemotaxis chambers in response to 
chemoa ttractant is expressed longitudinall y at 0 (pretreatment), 
2, 4 (d urin g treatment), and 6 months (2 months after cessation 
of treatment) . T he mean ± SEM is shown at each time point, 
the duration of isotretinoin trea tment is shown with hori zontal 
arrows , and values that are statistica lly different from pretreat-
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Figure 1. Effect ofisotretinoin on cellular chemotaxis in vivo. Thousa nds 
of cells per chamber are noted for monocytes and neutrophils at each time 
interva l. Bars and brackets arc mean ± SEM. Horiz olltal arrolVS indicate 
duration ofisotretinoin treatment. Statisti ca lly significant differences from 
control are noted with p values. 
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Figure 2. Photo microg raphs or in vivo chemotax is. A , T hree-mi cron pore chemotacti c filter fro m patient prio r to iso tretino in treatm ent . A dense 
la ye r o f cells is seen (X 400) . B, Similar filter from patient after 4 m onths on iso tretinoin . No ce ll s arc secn ( x 400). C, Ph otomi crog raph o f H & E-
stained section of patient's skin chamber site pri or to isotretino in treatment (x 100) . Note th e t ransepiderm al mi gration o f neutrophils and m o nocy tes 
and accumulat io n o r infl amma to ry cel ls in th e upper dermis. 0, Ph o to micrograph of H & E-sta incd sec tio n fro m biopsy of skin chamber site of 
patient's skin after 4 months on iso tretin oin treatment (x 100). N o transepiderm al migration of neutrophils is seen . 
ment va lues arc indi catcd w ith their p va lu cs. Hi ghl y signi fi ca nt 
inhibitio n of both m onocy te and neutro phil chcmotax is was seen 
at 2 and 4 m onths (98% inhibition. p < 0.0001) durin g th e time 
of m ax imal cl ini ca l respo nse to iso tretin o in trea tm ent. C hemo-
ta xis had returl1 ed to pretrea tm ent levels by the 6th m onth (2 
m onths off treat ment). 
Figure 2A shows the dense cellul ar infil trate o n a rep resentati ve 
3-l-Lm pore filte r fro m a patient at 0 m onths (pretreatm ent). With 
hig h magn ificatio n (400 x o r 1000 x ), th e bright red cy top lasmi c 
staining of monocy tes and g reen poly m o rphonu clear m o rpho l-
ogy o f neutro phi ls ca n be easil y identified . Figure 28 shows a 
similar fi lter from a patient at 2 months (1.5 m g/kg isotretino in 
fo r 2 months) . In thi s fi lter no cell s we re present; o nl y the 3-l-Lm 
po res arc visib le o n fi lters harves ted durin g th e period of isot re-
tin o in trea tmen t, o nl y sm all numbers of cells were seen on the 
fi lter o r found in the cham ber flu id. 
To determine w hether the lack of cell s seen in the skin chambers 
was due to fa ilure to attach to the chamber fi lters, fa ilure to to tall y 
cross th e epidermis, o r failure to enter the ep idermis. we obta ined 
biopsies from several skin chamber sites imm ed iate ly after re-
m ov in g the chambers. Figure 2C shows a representat ive bio psy 
of a cham ber site containing 50% autologo us ZAS from a patient 
at 0 m o nths. One observes a thin epi cutaneo us amorpho us area, 
epidermal spongiosis and basa l zone disruption . and neutro phils 
and m onocytes sin g ly and in g ro ups traversin g the epidermis. 
N eutro phils and mon ocytes arc also seen aro und blood vessels in 
the dermis and adj acent to the ep idermis. In contrast , Fig 2D 
shows a bio psy taken fro m a pati ent receivin g iso tretin o in. There 
is no evidence of epiderma l dama ge, there arc no cell s w ithin the 
epidermis, and there are onl y a very few m o nonuclear cell s around 
th e blood vessels in the papi ll ary dermis. O ne does not see neu-
trophi ls aroun d dermal vessels. retarded under the epiderm is, or 
in transit through the ep iderm is. Immuno flu o rescent s taining fo r 
co mplem ent showed g ranular depos its of C3 in the epidermis, at 
th e derm al-epidermal jun cti o n, and aro und vesse ls in th e papi ll ary 
dermi s in bio psies taken before and durin g isotretin o in treatment. 
impl yin g th at co mplement from the epicutaneous chamber could 
diffuse in to and thro ug h the epidermi s even in pati ents receiving 
iso tretino in. No such depos its were seen in no rm al skin adj acen t 
to skin chamber sites . 
The in vitro chemotactic response of periphera l blood 111 0 no-
cy tes and neutrophil s fro m patients tak in g isotretin oin is shown 
in Fig 3. The numbers are ex pressed as percent of norma l contro l. 
and the "100% va lue fo r co ntro ls is shown as a ho rizontal dotted 
li ne. T he bars represent th e m ea n + SEM for th e sa m e 7 patients 
at 0 (pretrea tment) , 2, 4 (d uring trea tm ent) , and 6 m o nths (post 
treat m ent) o f study . T he o nl y signifi cant differen ce of in vitro 
chem o ta x is between patients with acne and controls was seen in 
pretreatm ent peripheral b lood neutrophils fr o m the patients; th e 
cell s from pati en ts with acne showed sig nifi ca ntly enh anced mi-
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Figure 3. In vitro chemotaxis of peripheral blood leukocytes from pa-
tients on isot retinoin . Monocyte and neutrophil responses (expressed as 
percent of normal control) at different intervals. Duration of isotretinoin 
treatment is noted by horizomal arrow. Significant diffe rences from norm al 
controls are shown with p value·s. 
g ration to attractants (p < 0.001). N o diminished chemotactic 
response across po lycarbonate fi lters was seen th at cou ld explain 
the pro found (98%) inhibition in vivo across bio logic barriers. 
The diminished chemotactic responses o bserved in vivo were 
produced usin g autologous ZAS in the skin chambers, and one 
possible expl anation of the d ichotomy between the in vitro and 
in vivo results could have been that the serum from isotretinoin-
treated patients could not be activated to produce at tractants. This 
possibility was tes ted in vitro by activating norm al serum and 
sera from patients ob tained before and during iso tretinoin treat-
m ent , and then comparing the efficacy of these activated sera as 
chemoattractants . Table I shows the chemotactic response of neu-
trophils to ZAS derived from normal sera and from isotretinoin-
treated patient sera. N o signifi cant differen ces were seen . 
To determine w hether the sera of patients trea ted w ith isotre-
tinoin contained inhibitors of m o nocyte and neutrophil chemo-
Table I. Serum from Isotretinoin-T reated Patien ts as a 
Source of C hemoattractants 
Monocyte migra tion in vitro to ZAS derived from: 
Normal human serum 
Patients wi th acne: pretreatment 
Patients with acne: 4 months on isotretinoin 
390 ± 30" 
427 ± 8 N S 
413 ± 27 NS 
Mean :!: SEM of the mig rated cells in 20400 X rando m microscope ficId s. Mean 
of 3 experiments using different acne patients' serum in each ex periment. 
NS = no significant differen ce fro m control; Z AS = zy mosan-activated se rllm . 
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Figure 4. Effects of incubation of serum and plasma from isotretinoin-
treated subjects on leukocyte chemotaxis in vitro. Migrated monocytes 
and neutrophils per 20 fields at 1000 X are noted after incubation with 
plasma and sera from different in tervals of trea tment. No significant 
differences were seen . 
taxis, plasm a and sera from patients were added to monocytes 
and neut roph ils, the cel ls were in cubated for 30 min at 4°C in a 
dark refrigerator , and then used in chem otactic experiments. T he 
resul ts are shown in Fig 4. N o significant differences were seen 
using sera or pl as m a from patients durin g trea tmen t (2 and 4 
m onth s) or after treatment (6 m onths) w hen in v ivo chemotactic 
responses had returned to normal levels. 
In the fina l series of experiments, we tes ted w hether light-
protected cells fro m patients receivin g isotretinoin showed dif-
ferent in vi tro chemotac tic responses from the sa m e cells delib-
erately exposed to laboratory ambient light. Table II shows the 
m onocyte and neutrophil chem o tactic responses from ligh t- ex-
posed and lig ht-protected cells. No significant difference in either 
m onocyte or neutrophi l chemotaxis was seen when cells from 
isotretin o in-treated patien ts were light protected or purposel y 
exposed to ambient li ght. 
DISCUSSION 
We have demonstrated a profound inhibition of monocyte an d 
neut rophil chem o tactic responses in v ivo to ZAS in patients tak-
in g therapeutic doses o f isotretinoin. This response returned to 
norm al within 2 m on ths of discontin uin g the drug. Biopsy of 
skin chamber sites showed that there was no significant dermal 
Table II. Effect of Light Exposu re or Protection on the 
C hemotacti c Res ponse of Cells From Patients Taking 
Isotretinoin 




242 ± 18a 
453 ± 381> 
N S = no signi ficant difference from control. 
' Mean :!: SEM of the monocytes in 20 fields at 1000 X . 
' Mea n :!: SEM of the neutrophils in 20 ficlds at 1000 X . 
Light-Protected 
315 ± 47 NS 
326 ± 34 NS 
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or epidermal infiltrate in res ponse to auto logous Z AS in patients 
receiving th erapeutic doses of iso tretin oin . The activa ted autolo. 
gaus serum used in these experiments w as as po tent as acti va ted 
normal serum in inducing chemota ctic responses in vitro . Pe-
ripheral blood neutrophils and monocytes from the same iso tre-
tin oin-treated subj ects showed no redu ced chemotactic responses 
in vitro, even w hen studied under li ght-protected conditions. 
Serum and plas ma from isotretin oin-trea ted subj ects did not di-
rectl y inhibit neutrophil o r m onocyte chemotaxis in vitro. We 
consistentl y fo un d that the in vi vo chemotacti c responses of 
monocy tes and neutrophil s across intact bio logic barriers were 
severely inhibited by isotretin oin , whereas the chemotac ti c re-
sponse of peripheral blood cells from the same patients across 
thin chemotaxis filters was intact . 
Since the report o f Plewig and Wagner (7] that isotretin oin 
inhi bited pustule fo rm ati on in potassium iodide patch tes ts, there 
has been considerable debate wheth er retinoids directl y affect neu-
trophilmigration, o r w hether retinoids merely inhibit neutrophil 
effector fun ctions. Ca lTlisa and coworkers showed that incubation 
of neutro phils w ith retin oids in vitro signifi ca ntl y inhibited neu-
tro phi l enzy me release and superoxide anion produ ction but did 
not directl y affect the chemotacti c response [8]. T hey also showed 
preliminary evidence that the sera o r pl asma from people takin g 
isotretinoin mi ght contain metabolites o f th e drug that could 
inhibit neutrophil fun ction w hen added to normal neutrophi ls in 
vitro. Shalita and Lee [9] showed th at pharm acologic concentra-
tions of isotretin oin inhibited neutro phil chemiluminescence in 
vitro, and that iso tretinoin was much more po tent in this regard 
than were etretin ate o r tretin oin . H owever, th ey co uld directly 
inhibit chemotaxis and bacteri cidal fun ction only at sup ra phar-
macologic levels (10-3 molar), which we have found to be directl y 
cytotoxic to neutrophil s (T onnesen and N orris, unpublished ob-
servations). Bauer and coworkers [14] found th at neutrophils from 
pso riati c pati ents takin g the aro nlatic retinoid etretinate had im-
paired surv ival, and random mi gra ti on in vitro , possibl y asso-
ciated w ith a defect in micro tubul e fun cti on. However, the ma-
jo rity of evidence fro m in vitro ex periments indi ca tes th at 
neut rophi ls exposed to therapeuti c levels of retinoids ca n o rient 
and migrate under the in flu ence o f chemotactic g radi ents, at least 
in standard filter chemotaxis assays. 
[n contras t, th ere is stron g evidence indica tin g th at retin oids 
can inhibit neutrophil mi gration in vivo across intact bio logic 
barriers. Dubertret and colleagues repo rted that etretin ate and its 
maj or metabolite produced significant inhibition of neutrophil 
migration lISing a suction-bli ster chemotaxis technique (15] . T hey 
were able to produ ce up to 50% inhibition of mi gration by in-
j ecting the major etretinate metabolite into the blister cavity. In 
the experim ents that w e report here, we were able to produce 
98% inhibition of chemotactic responses by o ral administration 
of therapeuti c doses of isotretin oin. The grea ter level of inhibition 
seen in our experiments when compared with Dubertret's res ults 
is probabl y a direct result of the in vivo chemotacti c technique 
we used. This technique was developed because o f the very low 
level of spontaneous migration observed because of the very gentle 
m eans of removal of the stratum corneum [10]. These two reports 
corrobora te the findin g that neutrophil chemotactic responses in 
vivo can be greatly inhibited by therapeutic doses o f retin oids. 
Using th e sa me technique, we have been able to produce only 
50% inhibition of chemotaxis w ith pharm acologic doses of co r-
ticosteroids (11] . 
[n an animal model , the chemotactic response o f rat periton eal 
macrophages to inj ection o f chemotac ti c agents was blocked by 
aromati c retinoid therapy [1 6]. Additional support comes from 
th e findin g of Barr and coworkers (1 7], w ho studied the effect 
of etretinate on pso riati c skin . They quantitated vari ous eicosa-
noids in norma l and psoriati c skin before and durin g etretin ate 
th erapy. T hey found th at the powerful neutrophil attractant leu-
ko triene B4 (L TB4) was still produced in psoriatic skin durin g 
etretin ate trea tment, but th at no neutrophil res ponse to the at-
trac tant was observed. Other investi gato rs, however, have re-
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ported that retin oids inhibit bo th L TB4 release and bio logic effect 
(1 8]. 
C hemotacti c responses in vivo require no t j ust o rientation and 
directed m ovement toward a g radient of attractants, but also other 
bio logic fun ctions to traverse the many stru ctural barriers present 
in tissue. In vivo, neutrophils must adh ere to vascular endothe-
lium , o rient· to the chem otactic g radient, and th en probably se-
crete pro teases which disrupt vascular basement membrane and 
dermal and epidermal barriers, as they migrate under the influence 
of the chemotactic g radient tow ard the source of the chemoa t-
tractant [1 9- 21] and th en und ergo stimulated pro tease rel ease, 
w hich may contribute to tiss ue injury. Protease inhibition has 
been impli ca ted as a clinica lly relevant effect of retinoids. In ad-
ju va nt ar thriti s in rats, isotretin oin signifi cantly inhibits the col-
lagenase release that is associated w ith j o int inflammation (22] . 
As previously no ted, Camisa and coworkers w ere among the first 
to demonstrate inhibition by retinoids of pro tease release from 
hum an neutrophils (8]. 
The results reported here show that isotretinoin profoundl y 
inhibited bo th neutrophil and monocyte chem otaxis in vivo in 
patients taking the medication fo r cysti c acne. This result was not 
du e to the effect of the drug on th e ability o f monocytes and 
neutrophi ls to respond to chemotactic fa ctors across non biologic 
barriers in vitro , and was not due to inhibition of chemoattractant 
gcneration. We postulate that the therapeutic effect ofisotretinoin 
in inflammatory acne is du e in part to the strong Inhibitory effect 
on human monocyte and neutrophil chemotaxis in vivo. We spec-
ulate that th e drug inhibits the movement of stimulated neutro-
phils and monocy tes across bio logic barriers such as the vascular 
endothelium o r basement membranes. O f course, its effect on 
secondary chem oa ttractant fac tor generation needs to be exa m-
incd experimentally. Finally, these findin gs in patients w ith cys tic 
acnc taking isotrctinoin may apply to other neutrophil-mediated 
di seases res ponsive to this drug , such as pustular pso rias is. 
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